Skip to main content
. 2013 Jun 3;288(28):20326–20333. doi: 10.1074/jbc.M113.484550

FIGURE 4.

FIGURE 4.

F1086A inhibits ATP-dependent cross-linking at the extracellular surface. A and B, membranes prepared from cells expressing mutant T333C/L975C (A) or T333C/L975C/F1086A (B) were treated with BMOE in the absence (None) or presence of nucleotides (ATP, AMP-PNP, or ADP). Samples were subjected to immunoblot analysis. The positions of the cross-linked (X-link) and mature (170 kDa) P-gps are indicated.